The global in vitro fertilization (IVF) market was valued at USD 28.5 billion in 2025 and is projected to reach USD 43.7 billion by 2033, expanding from USD 30.1 billion in 2026 at a CAGR of 5.5% from 2026 to 2033. Europe led the global market in 2025, accounting for 37.0% of total revenue. Increasing infertility rates among men and women, rising reproductive tourism, delayed parenthood, and growing adoption of assisted reproductive technologies (ART) are among the major factors supporting market growth.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

In Vitro Fertilization Market: Key Highlights

• 2025 market size: USD 28.5 billion
• 2026 estimated market size: USD 30.1 billion
• 2033 projected market size: USD 43.7 billion
• CAGR, 2026–2033: 5.5%
• Largest regional market: Europe, with a 37.0% revenue share in 2025
• Fastest-growing region: Asia Pacific, based on the highest CAGR during 2026–2033

Key Market Trends and Insights

By instrument: The culture media segment accounted for the largest share of the IVF market, representing approximately 41.0% of the market in 2025. Culture media play an important role in supporting embryo development during IVF procedures, contributing to their widespread use in fertility laboratories.

By procedure type: The frozen non-donor segment held the largest market share in 2025. Increasing adoption of cryopreservation and embryo freezing technologies is supporting demand for frozen IVF procedures.

By provider: Fertility clinics represented the largest provider segment in 2025, supported by their specialized infrastructure, fertility-care expertise, and increasing patient preference for dedicated reproductive health centers.

Go Deeper! Ask Prism AI

about the Global in vitro fertilization market. Get instant answers to questions related to market sizing, growth drivers & their impact, and more.

Market Growth Drivers

Rising Infertility Rates

Infertility is a significant reproductive health concern worldwide. According to the World Health Organization (WHO), approximately 17.5% of adults globally experience infertility, highlighting the need for accessible, affordable, and high-quality fertility care.

Male infertility is also a substantial contributor to overall infertility. The American Pregnancy Association has reported that male infertility accounts for approximately 30% of infertility cases and contributes to a significant proportion of infertility cases in the U.S. The increasing prevalence of male and female infertility is consequently driving demand for assisted reproductive technologies, including IVF.

Delayed Parenthood and Changing Family-Planning Patterns

The average age at marriage and first childbirth has increased in many markets. Delayed parenthood has contributed to greater demand for fertility preservation and assisted reproductive procedures, particularly among women seeking to maintain reproductive options later in life.

Egg freezing has also gained attention among individuals who choose to postpone parenthood for career, personal, or other reasons. Growing awareness of fertility preservation and increasing reliance on assisted reproductive solutions are expected to support IVF market expansion.

Technological Advancements in IVF

Continuous innovation in reproductive medicine is improving the efficiency and potential success of IVF procedures. Technologies and techniques such as egg and sperm freezing, vitrification, assisted hatching, Percutaneous Epididymal Sperm Aspiration (PESA), and Testicular Sperm Extraction (TESE) are expanding treatment options for patients with different infertility conditions.

The development of new laboratory products, fertility technologies, and digital solutions is also contributing to improvements across the IVF treatment workflow.

For example, in June 2025, Cercle entered into a global distribution partnership with MedITEX to expand access to its AI platform across fertility and genetics clinics in Europe. Such partnerships demonstrate the increasing integration of artificial intelligence and digital technologies into fertility-care workflows.

Download a free sample report or claim your copy of this full market intelligence report

Digital Transformation in Fertility Care

Digital engagement is becoming increasingly important for fertility clinics, hospitals, and IVF-related manufacturers. Organizations are using digital platforms to improve awareness of infertility treatments, communicate treatment options, and establish stronger relationships with prospective patients.

However, infertility remains a sensitive subject in many societies, particularly in developing countries, where patients may be reluctant to discuss reproductive health openly. As a result, trust, authenticity, transparency, and digital credibility have become important considerations for fertility-care providers.

Clinics and manufacturers can strengthen patient confidence by clearly displaying relevant certifications and approvals, introducing qualified physicians and scientists, providing verifiable organizational information, and communicating treatment expertise through credible digital channels.

Regional Insights

Europe

Europe was the largest regional market for IVF in 2025, accounting for 37.0% of global revenue. The region's leading position is supported by established fertility-care infrastructure, availability of assisted reproductive technologies, growing demand for fertility treatment, and increasing reproductive tourism.

Asia Pacific

Asia Pacific is expected to register the fastest CAGR from 2026 to 2033. Increasing awareness of infertility treatments, improving healthcare infrastructure, rising disposable incomes, growing medical tourism, and expanding access to assisted reproductive technologies are expected to create significant opportunities across the region.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Analyst Perspective

The global IVF market is being shaped by the increasing incidence of infertility, delayed parenthood, rising awareness of assisted reproductive technologies, and continued advances in fertility treatment. The growing availability of fertility preservation, cryopreservation, and AI-enabled solutions is further expanding the range of treatment options available to patients.

Emerging markets represent an important growth opportunity as fertility providers expand access to reproductive healthcare and digital patient-engagement platforms. Increasing investment in reproductive healthcare, technological innovation, and AI-driven diagnostics and treatment-support tools could further strengthen market development.

At the same time, high treatment costs, limited insurance coverage, regulatory differences, and social stigma surrounding infertility remain important barriers to wider IVF adoption.

Competitive Landscape

The global IVF market includes fertility-treatment providers, pharmaceutical companies, medical-device manufacturers, laboratory technology companies, and reproductive-health solution providers. Leading companies are focusing on product development, technology integration, strategic partnerships, geographic expansion, and solutions designed to improve IVF laboratory and clinical outcomes.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Key companies profiled in the in vitro fertilization market study include:

• Cook Medical LLC
• EMD Serono, Inc.
• Ferring B.V.
• FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
• Genea Biomedx
• Merck KGaA (EMD Serono)
• The Cooper Companies, Inc.

Explore our dedicated business services:

U.S. Healthcare Facility Mapping & Intelligence Platform: Get facility-level intelligence to guide smarter decisions. Sign up Today